Latest Financials News

ReadCloud Limited’s 1H26 results reveal robust growth in school-focused businesses, with cash receipts up 22% and operating cash flow rising 10%, positioning the company to outperform its FY26 earnings guidance.

FirstWave Cloud Technology posted a cash-flow positive Q3 FY26 with a 125% jump in customer receipts and locked in landmark contracts with Banobras and Services Australia, underpinning its AI-driven compliance strategy.

Champion Iron Limited reported a 19% increase in net profit to C$168.7 million for FY2026, driven by record production and sales, progress on its DRPF project, and the strategic acquisition of Rana Gruber.

VRX Silica has kicked off a $6.23 million renounceable entitlement offer, underwritten to $2 million, to fund key development activities at its Arrowsmith North silica sand project including a strategic property purchase and engineering works.

Accelerate Resources has raised A$2 million in a two-tranche placement to fund aggressive exploration at its Balagundi Gold and Woodie Woodie North Manganese projects, aiming for a busy news flow through 2026.

Terragen Holdings secures a landmark supply agreement for its probiotic and biostimulant products with Ravensworth Feedlot, alongside a $2.8 million funded trial at Mort & Co’s Grassdale feedlot to validate its probiotic’s impact on cattle performance.

BPH Global Ltd (ASX: BP8) posted its second best monthly seaweed trading result with gross sales of approximately A$391,000 in the twelfth month, pushing aggregate sales beyond A$3.3 million as Indonesian operations scale up post-monsoon.

Li-FT Power Ltd. has released an extensive update to its Corporate Governance Statement, outlining its board structure, committee roles, and compliance with Canadian and ASX governance standards. The company highlights partial adherence to some ASX recommendations, reflecting its current development stage.

Imugene has dosed the first patient in a new cohort combining its azer-cel CAR T therapy with BTK inhibitors, targeting patients with B-cell malignancies who failed prior BTKi treatment. This move broadens the trial’s scope and tackles a significant unmet need in blood cancer therapy.

Peet Limited has upgraded its FY26 net profit guidance by up to 17%, driven by accelerated construction and robust market demand in Western Australia and Queensland.

Beonic Ltd (ASX:BEO) has initiated a $3 million pro-rata renounceable entitlement offer at $0.08 per share, partially underwritten by Alpine Capital, to shore up working capital and repay shareholder loans. The offer carries potential dilution of 35.7% for non-participating shareholders and may increase the Thorney Group's voting power significantly.

Select Harvests delivered a 33% rise in underlying NPAT despite a wet harvest and higher costs, announcing a fully franked interim dividend and a 10% on-market share buy-back.